1. Home
  2. AVT vs PTCT Comparison

AVT vs PTCT Comparison

Compare AVT & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avnet Inc.

AVT

Avnet Inc.

HOLD

Current Price

$88.84

Market Cap

7.1B

Sector

Technology

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$68.01

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVT
PTCT
Founded
1921
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.5B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
AVT
PTCT
Price
$88.84
$68.01
Analyst Decision
Hold
Buy
Analyst Count
3
17
Target Price
$59.33
$80.65
AVG Volume (30 Days)
917.6K
1.3M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
264.48
EPS
2.49
0.90
Revenue
$22,200,754,000.00
$264,734,000.00
Revenue This Year
$14.39
N/A
Revenue Next Year
$5.44
$17.70
P/E Ratio
$35.08
N/A
Revenue Growth
N/A
36.19
52 Week Low
$44.25
$43.18
52 Week High
$95.26
$90.87

Technical Indicators

Market Signals
Indicator
AVT
PTCT
Relative Strength Index (RSI) 52.75 28.53
Support Level $81.80 $68.16
Resistance Level $88.16 $72.09
Average True Range (ATR) 2.69 3.19
MACD -0.02 -1.23
Stochastic Oscillator 63.17 24.59

Price Performance

Historical Comparison
AVT
PTCT

About AVT Avnet Inc.

Avnet Inc is an electronic component technology distributor and solutions provider. It serves customers from startups and mid-sized businesses to enterprise-level original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, and original design manufacturers (ODMs). The group operates in the Electronic Components segment and supports high and medium-volume customers to markets, sells, and distributes electronic components, and the Farnell segment supports lower-volume customers that need electronic components quickly to develop, prototype, and test their products. Its geographic regions are the Americas, EMEA, and Asia.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: